965 Results

People

  1. Pasternak
    Pasternak
  2. Schwartz
    Schwartz
  3. Marks
    Marks
  4. Rosen
    Rosen
  5. Scher
    Scher
  6. De Stanchina
    De Stanchina
  7. Moore
    Moore
  8. Motzer
    Motzer
  9. Chou
    Chou
  10. Saltz
    Saltz

Groups

  1. Department of Medicine (366)
  2. GSK Faculty (226)
  3. Sloan Kettering Institute Faculty (208)
  4. Solid Tumor Oncology Division (204)
  5. Molecular Pharmacology and Chemistry Program Faculty (127)
  6. Hematologic Malignancies, Division of (119)
  7. Sloan Kettering Institute Postdocs (113)
  8. Center for Hematologic Malignancies (108)
  9. Surgery (103)
  10. Survivorship Research (91)
  1. "drug effect"
Formats
  1. Journal Article (897)
  2. Review (24)
  3. Conference Paper (23)
  4. Editorial (10)
  5. Research Letter (8)
  6. Guidelines (2)
  7. Book Section (1)
Groups
  1. Department of Medicine (366)
  2. GSK Faculty (226)
  3. Sloan Kettering Institute Faculty (208)
  4. Solid Tumor Oncology Division (204)
  5. Molecular Pharmacology and Chemistry Program Faculty (127)
  6. Hematologic Malignancies, Division of (119)

More Groups

People
  1. Gavril Pasternak (27)
  2. Gary Schwartz (21)
  3. Ting-Chao Chou (21)
  4. Paul Marks (20)
  5. Howard Scher (18)
  6. Neal Rosen (18)

More People

Years
  1. 2025 (28)
  2. 2024 (85)
  3. 2023 (10)
  4. 2022 (13)
  5. 2021 (10)
  6. 2020 (19)

More Years

Publications
  1. Journal of Clinical Oncology (43)
  2. Clinical Cancer Research (40)
  3. Blood (25)
  4. Cancer Research (22)
  5. Proceedings of the National Academy of Sciences of the United States of America (19)
  6. Nature Communications (14)

More Publications

Publishers
  1. American Association for Cancer Research (89)
  2. Nature Publishing Group (78)
  3. Elsevier Inc. (73)
  4. Springer (47)
  5. American Society of Clinical Oncology (44)
  6. Elsevier Science, Inc. (39)

More Publishers

Results (965)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with hormone receptor-positive, HER2-positive advanced breast cancer (monarcHER): A randomised, open-label, phase 2 trial
    Journal Article

    Tolaney, S. M.; Wardley, A. M.; Zambelli, S.; Hilton, J. F.; Troso-Sandoval, T. A.; Ricci, F.; Im, S. A.; Kim, S. B.; Johnston, S. R.; Chan, A.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • Tocilizumab not associated with increased infection risk after CAR T-cell therapy: Implications for COVID-19?
    Research Letter

    Frigault, M. J.; Nikiforow, S.; Mansour, M. K.; Hu, Z. H.; Horowitz, M. M.; Riches, M. L.; Hematti, P.; Turtle, C. J.; Zhang, M. J.; Perales, M. A.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Silibinin down-regulates PD-L1 expression in nasopharyngeal carcinoma by interfering with tumor cell glycolytic metabolism
    Journal Article

    Sellam, L. S.; Zappasodi, R.; Chettibi, F.; Djennaoui, D.; Yahi-Ait Mesbah, N.; Amir-Tidadini, Z. C.; Touil-Boukoffa, C.; Ouahioune, W.; Merghoub, T.; Bourouba, M.
    Archives of Biochemistry and Biophysics (2020)

    Fulltext@MSK | Save
  • Could BCG be used to protect against COVID-19?
    Editorial

    Redelman-Sidi, G.
    Nature Reviews Urology (2020)

    Fulltext@MSK | Save
  • TMPRSS2 and COVID-19: Serendipity or opportunity for intervention?
    Editorial

    Stopsack, K. H.; Mucci, L. A.; Antonarakis, E. S.; Nelson, P. S.; Kantoff, P. W.
    Cancer Discovery (2020)

    Fulltext@MSK | Save
  • Consensus recommendations for management and counseling of adverse events associated with lorlatinib: A guide for healthcare practitioners
    Guidelines

    Reed, M.; Rosales, A. L. S.; Chioda, M. D.; Parker, L.; Devgan, G.; Kettle, J.
    Advances in Therapy (2020)

    Fulltext@MSK | Save
  • Muramyl tripeptide-phosphatidyl ethanolamine encapsulated in liposomes (L-MTP-PE) in the treatment of osteosarcoma
    Journal Article

    Meyers, P. A.
    Advances in Experimental Medicine and Biology (2020)

    Fulltext@MSK | Save
  • Leukocytapheresis for patients with acute myeloid leukemia presenting with hyperleukocytosis and leukostasis: A contemporary appraisal of outcomes and benefits
    Review

    Shallis, R. M.; Stahl, M.; Bewersdorf, J. P.; Hendrickson, J. E.; Zeidan, A. M.
    Expert Review of Hematology (2020)

    Fulltext@MSK | Save
  • Selinexor: A first-in-class nuclear export inhibitor for management of multiply relapsed multiple myeloma
    Review

    Peterson, T. J.; Orozco, J.; Buege, M.
    Annals of Pharmacotherapy (2020)

    Fulltext@MSK | Save
  • The many faces of the anti-COVID immune response
    Editorial

    Vardhana, S. A.; Wolchok, J. D.
    Journal of Experimental Medicine (2020)

    Fulltext@MSK | Save